Selected article for: "confirm MERS cov infection and MERS cov infection"
Author: Crameri, Gary; Durr, Peter A.; Barr, Jennifer; Yu, Meng; Graham, Kerryne; Williams, Owen J.; Kayali, Ghazi; Smith, David; Peiris, Malik; Mackenzie, John S.; Wang, Lin-Fa
Title: Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread
  • Document date: 2015_11_2
    • ID: yxtepbta_17
    Snippet: Two different testing platforms were used to detect MERS-CoV antibodies in Australian camels. A Luminex assay based on the conserved and cross-reactive N proteins of both SARS-CoV and MERS-CoV was used to detect any antibodies cross reactive with either of these two viruses whereas the MERS-CoV specific VNT was employed to confirm the potential presence of MERS-CoV infection in Australian camels as the VNT assay is known to be specific for MERS-C.....
    Document: Two different testing platforms were used to detect MERS-CoV antibodies in Australian camels. A Luminex assay based on the conserved and cross-reactive N proteins of both SARS-CoV and MERS-CoV was used to detect any antibodies cross reactive with either of these two viruses whereas the MERS-CoV specific VNT was employed to confirm the potential presence of MERS-CoV infection in Australian camels as the VNT assay is known to be specific for MERS-CoV, and there is no crossneutralisation between MERS-CoV and SARS-CoV or bovine-CoV [28] .

    Search related documents:
    Co phrase search for related documents
    • antibody detect and Luminex assay: 1
    • antibody detect and MERS cov: 1, 2
    • antibody detect and MERS cov infection: 1
    • antibody detect and reactive cross: 1, 2, 3, 4, 5
    • australian camel and MERS cov: 1, 2, 3, 4, 5, 6, 7
    • australian camel and MERS cov infection: 1
    • bovine cov and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • bovine cov and reactive cross: 1, 2
    • Luminex assay and MERS cov: 1, 2, 3, 4
    • MERS cov and potential presence: 1, 2, 3, 4, 5, 6
    • MERS cov and reactive cross: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • MERS cov and testing platform: 1, 2, 3, 4, 5
    • MERS cov and virus reactive cross: 1, 2, 3
    • MERS cov and VNT assay: 1
    • MERS cov infection and potential presence: 1, 2
    • MERS cov infection and reactive cross: 1, 2, 3, 4
    • MERS cov infection and virus reactive cross: 1
    • MERS cov infection and VNT assay: 1
    • reactive cross and virus reactive cross: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49